Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8683896 | Epilepsy & Behavior | 2017 | 4 Pages |
Abstract
In patients with LOR-resistant SE, both LCM and SVA have comparable efficacy and safety.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Usha K. Misra, Deepanshu Dubey, Jayantee Kalita,